OPTOBIOTICS: Novel antibacterial proteins activated by blue light

Summary:

A Spanish public research institution has developed a chimeric protein that, when expressed in bacteria, changes its structure upon absorption of blue light, thus generating protein aggregates (amyloids) that inhibit bacterial growth

Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement.

Reference: TOES20190506004

Country: Spain

Submitted: 29. 11. 2019

View Partnering Opportunity

Keywords

Technology: Microbiology

Market: Genetic Engineering; Microbiology; Molecular design

NACE: -

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.